iShares Genomics Immunology and Healthcare ETF
IDNA
62 hedge funds and large institutions have $45.1M invested in iShares Genomics Immunology and Healthcare ETF in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 6 closing their positions.
1.87% more ownership
Funds ownership: 31.47% → 33.33% (+1.9%)
0% more capital invested
Capital invested by funds: $45.1M → $45.1M (+$37.4K)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
5% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 19
2% less funds holding
Funds holding: 63 → 62 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$1.96M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$1.04M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$504K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$413K |
| 5 |
Morgan Stanley
New York
|
+$390K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$894K |
| 2 |
SFFS
Stonehage Fleming Financial Services
St. Helier,
Jersey
|
-$465K |
| 3 |
PP
Prudential plc
London, England,
United Kingdom
|
-$389K |
| 4 |
PI
PFG Investments
Woodbury,
New York
|
-$357K |
| 5 |
NSAM
North Star Asset Management
Neenah,
Wisconsin
|
-$267K |
IDNA Hedge Fund Activity: Q2 2024 in Review
62 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q2 2024, worth a combined $45.1M — up 0.08% from $45.1M a quarter earlier.
Fund positioning in IDNA was balanced in Q2 2024: 6 funds opened new positions, 6 closed out, 18 added to existing stakes and 19 trimmed.
The largest buyer was Jane Street, adding an estimated $1.96M. The largest seller was Osaic Holdings, cutting an estimated $894K.
- 62 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q2 2024, down from 63 in Q1 2024.
- Funds reported $45.1M of iShares Genomics Immunology and Healthcare ETF stock for Q2 2024, up 0.08% quarter-over-quarter.
- 6 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q2 2024 and 6 closed out, a net change of 0 holders.
- The largest iShares Genomics Immunology and Healthcare ETF buyer in Q2 2024 was Jane Street, an estimated $1.96M added.
- The largest iShares Genomics Immunology and Healthcare ETF seller in Q2 2024 was Osaic Holdings, an estimated $894K sold.
Based on aggregated 13F filings for Q2 2024.